Speakers
Confirmed speakers:
Rolf Bjerkvig, University of Bergen
Klaus Bosslet, Roche Pharma Research and Early Development Penzberg
Mario Capecchi, University of Utah School of Medicine
Nils Cordes, OncoRay, TU Dresden
Jürgen Debus, Nationales Centrum für Tumorerkrankungen (NCT)
Dan G. Duda, Massachusetts General Hospital
Rosalind Eeles, Institute of Cancer Research
Steve Feldman, Center for Cancer Research, National Cancer Institute
Mathew Garnett, Wellcome Trust Sanger Institut
David Gonzales, The Institute of Cancer Research
William Hahn, Dana-Farber Cancer Institute
Sam Hanash, Fred Hutchinson Cancer Research Center
Brian Huntly, Cambridge Institute for Medical Research
Matthias Mann, Max Planck Institute of Biochemistry
Gillies McKenna, Gray Institute for Radiation Oncology & Biology
Cornelis Melief, Leiden University Medical Center
Jens Overgaard, Aarhus University Hospital
Klaus Pantel, UKE Institute for Tumor Biology
Stefan Pfister, German Cancer Research Center
Gail Lewis Phillips, Research Oncology,Genentech
George Prendergast, Lankenau Institute for Medical Research
Hans-Georg Rammensee, University of Tübingen
Elio Riboli, Imperial College London
Ugur Sahin, TRON and Mainz University Medical Center
Robert Schreiber, Washington University School of Medicine
Patrick Wen, Dana-Farber Cancer Institute
Kerri Winters-Stone, Oregon Health & Science University
Thomas Würdinger, VU Cancer Center
Wai-Kwan Alfred Yung, MD Anderson Cancer Center